Tag: clinical translation
-

Cardiologist Warns Australian Medical Research Crisis Today
The crisis warning from a leading cardiologist A prominent Australian cardiologist has sounded the alarm about a growing crisis in medical research across the country. The warning comes amid rising funding pressures, difficulties attracting and retaining top talent, and delays in translating laboratory discoveries into clinical practice. The expert argues that if these patterns continue,…
-

Switching Immune-Cold Tumors to Immune-Hot: A Breakthrough Path to Durable Cancer Immunity
Turning the Tide on Immune-Cold Tumors In a pivotal study published in Nature Immunology, scientists reveal a strategy that could make aggressive, immune-suppressive tumors more vulnerable to the body’s defenses. Funded by the National Cancer Institute/NIH, the research builds on prior work in breast cancer to show that transforming the tumor microenvironment can awaken a…
-

Ireland Advances Phase 2 of National Precision Oncology Program to Personalize Cancer Care
Ireland launches Phase 2 of its national precision oncology program On 8 October, Ireland marked a significant milestone in its fight against cancer as Minister for Further and Higher Education, Research, Innovation and Science James Lawless TD unveiled Phase 2 of Precision Oncology Ireland (POI). This country-wide effort stands as the largest and most ambitious…
-

Ireland launches Phase 2 of national Precision Oncology program to accelerate personalized cancer care
Ireland marks a new chapter in personalized cancer care with Phase 2 of Precision Oncology Ireland On 8 October, Ireland strengthened its commitment to precision medicine with the launch of Phase 2 of Precision Oncology Ireland (POI), the country’s leading and largest cancer research program. The initiative, announced by James Lawless TD, Minister for Further…
-

Ireland Expands Precision Oncology Ireland: Phase 2 Launch Poised to Transform Cancer Care
Ireland Launches Phase 2 of its National Precision Oncology Program On 8 October, Ireland marked a significant milestone in its fight against cancer with the launch of Phase 2 of Precision Oncology Ireland (POI). The event signals a bold expansion of the country’s leading cancer research program, built to advance personalised cancer research and patient…
-

Next‑gen imaging promises sharper, deeper views of living tissues
A bold step toward noninvasive, high‑resolution tissue imaging A University of Arizona research team is advancing a transformative approach to viewing living tissues noninvasively. With nearly $2.7 million from the NIH Common Fund Venture Program, the interdisciplinary effort aims to push the boundaries of optical imaging so clinicians can see deeper into skin and soft…
-

POI Phase 2: €28m to Accelerate Ireland’s Precision Oncology
Ireland’s Largest Cancer Research Programme Enters Phase 2 Ireland is accelerating its commitment to personalized cancer care as Precision Oncology Ireland (POI) enters its second phase. With a newly approved €28 million co-funding package, POI aims to scale its cross-sector model and deepen patient involvement, turning research breakthroughs into real-world diagnostics and treatments. What POI…
-

Next-Generation Imaging Promises Sharper, Deeper Views of Living Tissues
Breakthrough in Noninvasive Imaging Targets Deeper Tissue Insights A University of Arizona research team has received nearly $2.7 million from the NIH’s Common Fund Venture Program to push the boundaries of noninvasive optical imaging. Led by Florian Willomitzer, associate professor of optical sciences, and Dr. Clara Curiel-Lewandrowski of the U of A Comprehensive Cancer Center,…
